mifepristone has been researched along with Pain in 63 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (15.87) | 18.2507 |
| 2000's | 27 (42.86) | 29.6817 |
| 2010's | 15 (23.81) | 24.3611 |
| 2020's | 11 (17.46) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, BO; de Oliveira, D; de Oliveira, PV; Morgan, LV; Müller, LG; Oltramari, AR; Petry, F; Scapinello, J; Scatolin, M; Volfe, CRB; Zilli, GAL | 1 |
| Cameron, S; Evans, E; Johnstone, A; McCabe, K; Reynolds-Wright, JJ | 1 |
| Davis, J; Fontanilla, T; Friedlander, EB; Horiuchi, W; Kaneshiro, B; Raidoo, S; Salcedo, J; Soon, R; Tschann, M | 1 |
| Cameron, S; Morroni, C; Reynolds-Wright, JJ; Woldetsadik, MA | 1 |
| Heikinheimo, O; Kemppainen, V; Mentula, M; Palkama, V | 1 |
| Cameron, ST; Morroni, C; Reynolds-Wright, JJ; Woldetsadik, MA | 1 |
| Chen, KM; He, WR; Jiang, T; Liu, ZR; Wang, L; Wang, XW; Wei, H; Yi, C; Zeng, Y; Zhang, XF; Zheng, YH | 1 |
| Arnalsteen, C; Bettahar, K; Deshaies, A; Hauss, AS; Jochum, F; Kiehl, A; Koch, A; Martel, C | 1 |
| Chen, L; Jiang, Y; Kang, Y; Pan, J; Sun, J; Tang, D; Xu, W; Ye, H; Zhou, M; Zhu, J | 1 |
| Bessenaar, T; Dragoman, MV; Duong, LD; Gautam, J; Grossman, D; Gulmezoglu, M; Habib, N; Hong, M; Kapp, N; Nguyen, MH; Tamang, A; Yoko, JL | 1 |
| Flynn, AN; Jiang, E; Koelper, N; Martin, B; McAllister, A; Roe, AH; Schreiber, CA | 1 |
| Aabø, RS; Iversen, OE; Janbu, T; Løkeland, M; Pay, ASD; Økland, I | 1 |
| Choi, MG; Choi, SS; Jung, JS; Kang, YJ; Park, SH; Ryu, OH; Sim, YB; Suh, HW | 1 |
| Bjørge, L; Engeland, A; Iversen, OE; Løkeland, M; Økland, I | 1 |
| Bryant, AG; Regan, E; Stuart, G | 1 |
| Bombas, T; Cameron, S; Fiala, C; Gemzell-Danielsson, K; Parachini, M; Saya, L | 1 |
| Brolin, L; Hedqvist, M; Larsson, M; Tydén, T | 1 |
| Dragoman, MV; Dung, DL; Grossman, D; Habib, N; Huong, NM; Kapp, N; Tamang, A | 1 |
| Alessandri-Haber, N; Bogen, O; Brown, AS; Burkham, J; Dina, OA; Green, PG; Khasar, SG; Levine, JD; Reichling, DB | 1 |
| Bagaeva, TR; Filaretova, LP; Iarushkina, NI | 1 |
| Parsons, JH; Samuel, MI | 1 |
| Alexander, JK; Dahlman, JM; DeVries, AC; Kigerl, KA; Popovich, PG | 1 |
| Bonfiglio, T; Eisinger, SH; Fiscella, J; Fiscella, K; Meldrum, S | 1 |
| Bagaeva, TR; Filaretova, LP; Yarushkina, NI | 2 |
| Feng, C; Fiscella, K; Meldrum, S | 1 |
| Bagaeva, TR; Iarushkina, NI | 1 |
| Hewison, J; Howel, D; Kelly, T; Robson, S; Suddes, J | 1 |
| Kauppila, T; Kivinen, S; Suhonen, S; Tikka, M | 1 |
| Clark, TJ; Cooper, NA; Khan, KS; Smith, P | 1 |
| Avraham, S; Duvdevani, NR; Frenkel, Y; Gat, I; Haas, J; Seidman, DS | 1 |
| Bussieres, L; Camus, E; Fauconnier, A; Huchon, C; Machevin, E; Torre, A | 1 |
| Debu, E; Dufour, B; Fontan, JE; Langlade, A; Majorel, P; Scheller, E; Weber, B | 1 |
| Fielding, SL; Schaff, EA; Westhoff, C | 1 |
| Arici, A; Mahutte, NG | 1 |
| Ben-Chetrit, A; Eldar-Geva, T; Farhat, M; Gelber, H; Lindenberg, T; Shimonovitz, S; Sitruk-Ware, R; Spitz, IM; Zacut, D | 1 |
| Ashok, PW; Flett, GM; Hamoda, H; Templeton, A | 1 |
| Ai, Y; Guo, G; Lim, G; Mao, J; Sung, B; Wang, S; Yang, L; Zeng, Q | 1 |
| Lim, G; Mao, J; Sung, B; Wang, S; Yang, L; Zeng, Q | 1 |
| Lim, G; Mao, J; Wang, S | 1 |
| Knudsen, UB; Kristiansen, FV; Rasmussen, A; Ravn, P | 1 |
| Kurihara, T; Saegusa, H; Takasaki, I; Tanabe, T; Zong, S | 1 |
| Arvidsson, C; Gemzell-Danielsson, K; Hellborg, M | 1 |
| Dunn, S; Guilbert, E; Jacot, F; Shannon, C; Sheldon, WR; Wiebe, E; Winikoff, B | 1 |
| Li, YP; Liang, Y; Mei, L; Tong, L; Wu, SC; Yan, L; Zhang, JQ; Zou, Y | 1 |
| Cao, J; Dong, Z; Han, H; Mao, R; Xu, L | 1 |
| Jouppila, P; Martikainen, H; Niinimäki, M; Talvensaari-Mattila, A | 1 |
| Eisinger, SH; Feng, C; Fiscella, K; Fisher, SG; Guzick, DS; Meldrum, S | 1 |
| Gamerre, M; Guidicelli, B; Mazouni, C; Pellegrin, V; Voiret, C | 1 |
| Dempsey-Fanning, A; Teal, SB; Westhoff, C | 1 |
| Baker, ER; George, KE; Kapp, N; Lauria, MR; Mackenzie, T; Prairie, BA | 1 |
| El-Refaey, H; Templeton, A | 1 |
| Ashok, PW; Flett, GM; Templeton, A | 1 |
| Coyaji, K; Ellertson, C; Elul, B; Winikoff, B | 1 |
| Hahlin, M; Nielsen, S; Platz-Christensen, J | 1 |
| Levine, JD; Miao, FJ | 1 |
| Dumble, LJ; Klein, R | 1 |
| Ashok, PW; Fitzmaurice, A; Flett, GM; Graham, W; Kidd, A; Templeton, A | 1 |
| Dunn, S; Guilbert, E; Jacot, F; Lugtig, L; Wiebe, E | 1 |
| Eaton, MJ; Herman, JP; Huang, J; Jullien, N; Lopez, TL; Martinez, M | 1 |
| Baird, DT; Dewar, MH; Thong, KJ | 1 |
| Capasso, A; Di Giannuario, A; Loizzo, A; Pieretti, S; Sorrentino, L | 1 |
| Fontan, JE; Weber, B | 1 |
7 review(s) available for mifepristone and Pain
| Article | Year |
|---|---|
Pain management for medical abortion before 14 weeks' gestation.
Topics: Abortion, Induced; Abortion, Spontaneous; Acetaminophen; Female; Humans; Ibuprofen; Mifepristone; Misoprostol; Pain; Pain Management; Pregabalin; Pregnancy | 2022 |
Pain management for medical abortion before 14 weeks' gestation: A systematic review.
Topics: Female; Humans; Ibuprofen; Mifepristone; Misoprostol; Observational Studies as Topic; Pain; Pain Management; Pregnancy | 2022 |
An overview of medical abortion for clinical practice.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Aftercare; Chorionic Gonadotropin; Counseling; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pain; Pregnancy; Ultrasonography, Prenatal | 2014 |
Pain during medical abortion, the impact of the regimen: a neglected issue? A review.
Topics: Abortion, Induced; Adult; Analgesics; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pain; Pain Management; Pain Measurement; Pregnancy; Prospective Studies | 2014 |
Does cervical preparation before outpatient hysteroscopy reduce women's pain experience? A systematic review.
Topics: Ambulatory Care; Dilatation; Female; Hormone Antagonists; Humans; Hysteroscopy; Mifepristone; Misoprostol; Pain; Premedication | 2011 |
Medical management of endometriosis-associated pain.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Danazol; Endometriosis; Estrogen Antagonists; Female; Gestrinone; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Humans; Mifepristone; Pain; Pain Measurement; Progestins; Reproductive Control Agents | 2003 |
[Study on Meta analysis regarding the acceptability of medical abortion compared with surgical abortion].
Topics: Abortifacient Agents; Abortion, Induced; Choice Behavior; Controlled Clinical Trials as Topic; Female; Humans; Mifepristone; Misoprostol; Pain; Patient Satisfaction; Pregnancy; Pregnancy, Unwanted | 2006 |
24 trial(s) available for mifepristone and Pain
| Article | Year |
|---|---|
The experience of pain in real-time during medication abortion.
Topics: Abortion, Induced; Acetaminophen; Analgesics; Analgesics, Opioid; Female; Humans; Ibuprofen; Mifepristone; Misoprostol; Oxycodone; Pain; Pregnancy | 2022 |
Patient-controlled intravenous versus on-demand oral, intramuscular or mcs intravenous administration of oxycodone during medical induced abortion from 64 to 128 days of Gestation: A randomized controlled trial.
Topics: Abortion, Induced; Administration, Oral; Analgesia, Patient-Controlled; Analgesics; Female; Humans; Infant; Infusions, Intravenous; Mifepristone; Misoprostol; Oxycodone; Pain; Pregnancy; Prospective Studies | 2022 |
Evaluation efficacy and safety of epidural analgesia in second-trimester induced labor: A single-center, prospective, non-randomized, controlled study.
Topics: Analgesia, Epidural; Analgesia, Obstetrical; Analgesics; Anti-Bacterial Agents; C-Reactive Protein; Ethacridine; Female; Humans; Labor, Induced; Labor, Obstetric; Mifepristone; Pain; Pregnancy; Pregnancy Trimester, Second; Prospective Studies | 2022 |
Two prophylactic pain management regimens for medical abortion ≤63 days' gestation with mifepristone and misoprostol: A multicenter, randomized, placebo-controlled trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Female; Humans; Mifepristone; Misoprostol; Pain; Pain Management; Pregnancy | 2021 |
The effect of mifepristone pretreatment on bleeding and pain during medical management of early pregnancy loss.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pain; Pregnancy | 2021 |
Two prophylactic medication approaches in addition to a pain control regimen for early medical abortion < 63 days' gestation with mifepristone and misoprostol: study protocol for a randomized, controlled trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Antiemetics; Clinical Protocols; Double-Blind Method; Drug Administration Schedule; Female; Humans; Ibuprofen; Metoclopramide; Mifepristone; Misoprostol; Pain; Pain Management; Postoperative Nausea and Vomiting; Pregnancy; Research Design; Tramadol; Young Adult | 2016 |
Hygroscopic dilator (Dilapan-S) and misoprostol combination for the early first-trimester termination of pregnancy: a pilot study.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Dilatation; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pain; Pilot Projects; Polymers; Pregnancy; Pregnancy Trimester, First; Wettability | 2009 |
Open-label study of ultra low-dose mifepristone for the treatment of uterine leiomyomata.
Topics: Administration, Oral; Adult; Dose-Response Relationship, Drug; Female; Health Status; Hormone Antagonists; Humans; Leiomyoma; Middle Aged; Mifepristone; Pain; Quality of Life; Uterine Hemorrhage; Uterine Neoplasms | 2009 |
Comparing medical versus surgical termination of pregnancy at 13-20 weeks of gestation: a randomised controlled trial.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Aged; Aged, 80 and over; Dilatation and Curettage; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Pain; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Prospective Studies; Treatment Outcome; Vacuum Extraction, Obstetrical | 2010 |
Pre-emptive effect of ibuprofen versus placebo on pain relief and success rates of medical abortion: a double-blind, randomized, controlled study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chi-Square Distribution; Double-Blind Method; Drug Administration Schedule; Female; Hospitals, University; Humans; Ibuprofen; Israel; Logistic Models; Middle Aged; Mifepristone; Misoprostol; Odds Ratio; Pain; Pain Measurement; Placebos; Pregnancy; Prospective Studies; Surveys and Questionnaires; Time Factors; Treatment Outcome; Young Adult | 2012 |
Immediate versus delayed medical treatment for first-trimester miscarriage: a randomized trial.
Topics: Abortifacient Agents; Abortion, Spontaneous; Adult; Female; Hemorrhage; Humans; Infections; Mifepristone; Misoprostol; Pain; Pregnancy; Pregnancy Trimester, First; Treatment Outcome; Vacuum Curettage | 2012 |
Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pain; Pregnancy; Treatment Outcome; Uterine Hemorrhage | 2002 |
Mifepristone does not induce cervical softening in non-pregnant women.
Topics: Adult; Cervix Uteri; Double-Blind Method; Female; Hormone Antagonists; Humans; Hysteroscopy; Middle Aged; Mifepristone; Pain; Pain Measurement; Premedication; Progesterone; Treatment Failure | 2004 |
Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Administration, Topical; Analgesics; Female; Humans; Mifepristone; Misoprostol; Nausea; Pain; Patient Acceptance of Health Care; Patient Satisfaction; Pregnancy; Uterine Hemorrhage; Vagina; Vomiting | 2005 |
Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Female; Humans; Mifepristone; Misoprostol; Pain; Patient Satisfaction; Pregnancy; Treatment Outcome; Uterine Hemorrhage | 2006 |
A randomized study comparing efficacy and patient satisfaction in medical or surgical treatment of miscarriage.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Adult; Female; Humans; Incidence; Infections; Mifepristone; Misoprostol; Pain; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Treatment Outcome; Vacuum Curettage | 2006 |
Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial.
Topics: Adult; Female; Hormone Antagonists; Humans; Leiomyomatosis; Middle Aged; Mifepristone; Organ Size; Pain; Quality of Life; Treatment Outcome; Ultrasonography; Uterine Neoplasms; Uterus | 2006 |
Predictors of acceptability of medication abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pain; Parity; Patient Acceptance of Health Care; Pregnancy; Treatment Failure; Uterine Hemorrhage | 2007 |
Mifepristone versus laminaria: a randomized controlled trial of cervical ripening in midtrimester termination.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Cervical Ripening; Female; Humans; Labor, Induced; Laminaria; Mifepristone; Misoprostol; Pain; Pregnancy; Pregnancy Trimester, Second; Time Factors | 2007 |
Randomised trial comparing expectant with medical management for first trimester miscarriages.
Topics: Abortifacient Agents, Steroidal; Abortion, Spontaneous; Adult; Ambulatory Care; Chorionic Gonadotropin; Female; Humans; Length of Stay; Mifepristone; Pain; Placenta, Retained; Pregnancy; Pregnancy Trimester, First; Progesterone | 1999 |
A randomized comparison of medical abortion and surgical vacuum aspiration at 10-13 weeks gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Anesthesia, General; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pain; Patient Satisfaction; Postoperative Complications; Pregnancy; Treatment Outcome; Vacuum Curettage | 2002 |
Comparison of abortions induced by methotrexate or mifepristone followed by misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Female; Hemorrhage; Humans; Methotrexate; Mifepristone; Misoprostol; Pain; Pregnancy | 2002 |
What do women want during medical abortion?
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Acetaminophen; Administration, Oral; Adolescent; Adult; Alprostadil; Bias; Codeine; Female; Heroin; Humans; Mifepristone; Misoprostol; Pain; Patient Satisfaction; Pessaries; Pregnancy | 1992 |
Acetaminophen as a pain enhancer during voluntary interruption of pregnancy with mifepristone and sulprostone.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Acetaminophen; Dinoprostone; Double-Blind Method; Drug Interactions; Female; Humans; Male; Mifepristone; Pain; Pregnancy | 1990 |
32 other study(ies) available for mifepristone and Pain
| Article | Year |
|---|---|
Investigation of the anti-inflammatory effects of stigmasterol in mice: insight into its mechanism of action.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Inflammation; Male; Mice; Mifepristone; Molecular Docking Simulation; Pain; Peritonitis; Receptors, Glucocorticoid; Stigmasterol | 2021 |
Adherence to treatment and prevalence of side effects when medical abortion is delivered via telemedicine: a prospective observational cohort study during COVID-19.
Topics: Abortion, Induced; Anti-Bacterial Agents; Antiemetics; COVID-19; Female; Headache; Humans; Mifepristone; Misoprostol; Pain; Pregnancy; Prevalence; Prospective Studies; Referral and Consultation; Telemedicine; Telephone | 2022 |
[Single dose of misoprostol for abortion until 9 weeks of gestation].
Topics: Abortion, Induced; Administration, Intravaginal; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pain; Pain Management; Pregnancy | 2023 |
Stress Induces Prolonged Pain Recovery After Surgery: Involvement of Glucocorticoid-Related Pathway.
Topics: Animals; Brain; Disease Models, Animal; Glucocorticoids; Mice; Mifepristone; Pain; Stress, Psychological; Sucrose | 2023 |
Medical abortions performed by specialists in private practice.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Female; Gestational Age; Humans; Middle Aged; Mifepristone; Norway; Pain; Parity; Patient Safety; Patient Satisfaction; Pilot Projects; Pregnancy; Pregnancy Trimester, First; Private Practice; Self Administration; Surveys and Questionnaires; Uterine Hemorrhage; Young Adult | 2018 |
Interleukin-1β (IL-1β) increases pain behavior and the blood glucose level: possible involvement of glucocorticoid system.
Topics: Adrenal Glands; Adrenalectomy; Animals; Blood Glucose; Corticosterone; Corticotropin-Releasing Hormone; Glucose; Hormone Antagonists; Interleukin-1beta; Male; Mice; Mice, Inbred ICR; Mifepristone; Nociception; Pain; Pituitary Gland; Proto-Oncogene Proteins c-fos; Receptors, Glucocorticoid; RNA, Messenger; Spinal Cord | 2013 |
Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drug Therapy, Combination; Female; Gestational Age; Health Services Accessibility; Humans; Mifepristone; Misoprostol; Odds Ratio; Pain; Patient Acceptance of Health Care; Patient Satisfaction; Pregnancy; Prospective Studies; Self Administration; Travel; Uterine Hemorrhage | 2014 |
Women's experiences of having an early medical abortion at home.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Access to Information; Adolescent; Adult; Cross-Sectional Studies; Female; Gravidity; Hemorrhage; Humans; Middle Aged; Mifepristone; Pain; Patient Satisfaction; Pregnancy; Surveys and Questionnaires; Young Adult | 2016 |
Stress induces a switch of intracellular signaling in sensory neurons in a model of generalized pain.
Topics: Adrenalectomy; Analysis of Variance; Animals; Behavior, Animal; Corticosterone; Dinoprostone; Disease Models, Animal; Epinephrine; Hormone Antagonists; Hyperalgesia; Male; Mifepristone; Muscle, Skeletal; Neurons, Afferent; Pain; Pain Threshold; Rats; Rats, Sprague-Dawley; Signal Transduction; Skin; Sound; Stress, Physiological; Time Factors | 2008 |
[Analgesic effect of corticotropin releasing factor (CRF) on somatic pain sensitivity: participation of glucocorticoid and CRF-2 receptors].
Topics: Analgesics; Animals; Corticotropin-Releasing Hormone; Hormone Antagonists; Male; Mifepristone; Pain; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Receptors, Glucocorticoid; Time Factors | 2008 |
Stress exacerbates neuropathic pain via glucocorticoid and NMDA receptor activation.
Topics: Animals; Corticosterone; Extracellular Signal-Regulated MAP Kinases; Female; Mice; Mice, Inbred C57BL; Mifepristone; Pain; Pain Measurement; Peripheral Nervous System Diseases; Phosphorylation; Posterior Horn Cells; Receptors, Glucocorticoid; Receptors, N-Methyl-D-Aspartate; Restraint, Physical; Reverse Transcriptase Polymerase Chain Reaction; Stress, Psychological | 2009 |
Analgesic actions of corticotropin-releasing factor (CRF) on somatic pain sensitivity: involvement of glucocorticoid and CRF-2 receptors.
Topics: Analgesics; Animals; Corticotropin-Releasing Hormone; Hormone Antagonists; Male; Mifepristone; Pain; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Receptors, Glucocorticoid; Time Factors | 2009 |
Improved quality of life is partly explained by fewer symptoms after treatment of fibroids with mifepristone.
Topics: Adult; Anemia; Female; Hormone Antagonists; Humans; Leiomyoma; Middle Aged; Mifepristone; Organ Size; Pain; Quality of Life; Randomized Controlled Trials as Topic; Ultrasonography; Uterine Neoplasms; Uterus | 2010 |
[Mechanisms of corticotropin-releasing factor-induced analgesic effect in conscious rats].
Topics: Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents; Corticotropin-Releasing Hormone; Hormone Antagonists; Hormones; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Mifepristone; Naltrexone; Narcotic Antagonists; Pain; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley; Receptors, Opioid | 2010 |
Pain during medical abortion: predicting factors from gynecologic history and medical staff evaluation of severity.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Female; Humans; Medical Staff; Mifepristone; Misoprostol; Pain; Pain Measurement; Pregnancy; Statistics, Nonparametric; Surveys and Questionnaires; Young Adult | 2011 |
Effect of glucocorticoid receptor blockade on analgesic effect of corticotropin-releasing factor.
Topics: Analgesics; Animals; Corticosterone; Corticotropin-Releasing Hormone; Mifepristone; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid | 2011 |
[Abortion induced by mifepristone and sulprostone combination: attempting analgesia with acetominophen or dipropyline].
Topics: Abortion, Induced; Analgesia; Biology; Demography; Developed Countries; Disease; Double-Blind Method; Endocrine System; Europe; Family Planning Services; France; Hormone Antagonists; Hormones; Mifepristone; Pain; Physiology; Population; Population Dynamics; Pregnancy; Pregnancy Trimester, First; Prostaglandins; Prostaglandins, Synthetic; Reproduction; Research; Signs and Symptoms; Therapeutics; Time Factors | 1990 |
Analgesia requirements and predictors of analgesia use for women undergoing medical abortion up to 22 weeks of gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Analgesia; Analgesia, Obstetrical; Analgesics; Female; Humans; Mifepristone; Misoprostol; Pain; Pregnancy; Pregnancy Trimester, Second; Regression Analysis; Retrospective Studies | 2004 |
Expression of central glucocorticoid receptors after peripheral nerve injury contributes to neuropathic pain behaviors in rats.
Topics: Adrenalectomy; Animals; Blotting, Western; Constriction; Dexamethasone; Enzyme-Linked Immunosorbent Assay; Hyperalgesia; Immunohistochemistry; Interleukin-1; Ligation; Male; Mice; Mice, Knockout; Mifepristone; Neuralgia; Oligodeoxyribonucleotides, Antisense; Pain; Peripheral Nervous System Diseases; Protein Kinase C; Protein Kinase C-delta; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Reverse Transcriptase Polymerase Chain Reaction; Spinal Cord | 2004 |
Central glucocorticoid receptors modulate the expression and function of spinal NMDA receptors after peripheral nerve injury.
Topics: Animals; Behavior, Animal; Constriction; Dizocilpine Maleate; Hyperalgesia; Interleukin-6; Male; Mice; Mice, Knockout; Mifepristone; Oligodeoxyribonucleotides, Antisense; Pain; Peripheral Nerve Injuries; Peripheral Nervous System Diseases; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Receptors, N-Methyl-D-Aspartate; Spinal Cord | 2005 |
Central glucocorticoid receptors modulate the expression of spinal cannabinoid receptors induced by chronic morphine exposure.
Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Injections, Spinal; Male; Mifepristone; Morphine; Pain; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Glucocorticoid; Spinal Cord; Up-Regulation | 2005 |
An outpatient regimen of combined oral mifepristone 400 mg and misoprostol 400 microg for first-trimester legal medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Oral; Female; Follow-Up Studies; Gestational Age; Humans; Mifepristone; Misoprostol; Pain; Pregnancy; Pregnancy Trimester, First; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2005 |
Effects of glucocorticoid receptor antagonists on allodynia and hyperalgesia in mouse model of neuropathic pain.
Topics: Animals; Behavior, Animal; Calcium Channels, N-Type; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Profiling; Hormone Antagonists; Hyperalgesia; Injections, Intraventricular; Injections, Spinal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mifepristone; Motor Activity; Neuralgia; Oligonucleotide Array Sequence Analysis; Pain; Pain Threshold; Receptors, Glucocorticoid; Spinal Cord Injuries; Time Factors | 2005 |
Morphine withdrawal modifies antinociceptive effects of acute morphine in rats.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Drug Tolerance; Male; Mifepristone; Morphine; Morphine Dependence; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Glucocorticoid; Stress, Psychological; Substance Withdrawal Syndrome | 2006 |
Influence of epidural analgesia on labor in mid and late termination of pregnancy: an observational study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Age Factors; Amides; Analgesia, Epidural; Analgesia, Obstetrical; Anesthetics, Intravenous; Anesthetics, Local; Female; Humans; Labor, Induced; Mifepristone; Misoprostol; Pain; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Retrospective Studies; Ropivacaine; Sufentanil | 2007 |
Unsuccessful treatment of missed abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Missed; Female; Humans; Mifepristone; Misoprostol; Pain; Pregnancy; Uterine Hemorrhage | 1998 |
Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Analgesics; Diarrhea; Female; Follow-Up Studies; Gestational Age; Humans; Mifepristone; Misoprostol; Pain; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Uterine Hemorrhage; Vomiting | 1998 |
Side effects of mifepristone-misoprostol abortion versus surgical abortion. Data from a trial in China, Cuba, and India.
Topics: Abortifacient Agents; Abortion, Induced; Abortion, Legal; Adult; China; Cuba; Drug Therapy, Combination; Female; Hemorrhage; Humans; India; Mifepristone; Misoprostol; Pain; Pregnancy | 1999 |
Neural and endocrine mechanisms mediating noxious stimulus-induced inhibition of bradykinin plasma extravasation in the rat.
Topics: Adrenal Glands; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Bradykinin; Capsaicin; Electric Stimulation; Endocrine Glands; Hypophysectomy; Knee Joint; Male; Mifepristone; Naloxone; Narcotic Antagonists; Nervous System Physiological Phenomena; Neurons, Afferent; Pain; Phentolamine; Propranolol; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Sympathetic Nervous System; Synovial Fluid | 1999 |
RU 486/prostaglandin threats to safe pregnancy termination.
Topics: Abortion, Induced; Developing Countries; Drug Industry; Evaluation Studies as Topic; Female; Freedom; General Surgery; Government Regulation; Hazardous Substances; Human Experimentation; Humans; International Cooperation; Internationality; Methods; Mifepristone; Pain; Patient Care; Patient Compliance; Personal Autonomy; Pharmaceutical Preparations; Politics; Risk; Risk Assessment; Social Control, Formal; Women; Women's Health; Women's Rights | 1992 |
Immortalized chromaffin cells disimmortalized with Cre/lox site-directed recombination for use in cell therapy for pain after partial nerve injury.
Topics: Animals; Antigens, Viral, Tumor; Cell Count; Cells, Cultured; Chromaffin Cells; Disease Models, Animal; Dopamine beta-Hydroxylase; Gene Expression; Genetic Vectors; Hyperalgesia; Integrases; Mifepristone; Mutagenesis, Site-Directed; Norepinephrine; Oncogenes; Pain; Pain Management; Phenylethanolamine N-Methyltransferase; Rats; Rats, Inbred WF; Rats, Sprague-Dawley; Recombination, Genetic; Sciatic Neuropathy; Temperature; Thymidine Kinase; Transfection; Treatment Outcome; Tyrosine 3-Monooxygenase; Viral Proteins | 2002 |
The interaction of peripherally and centrally administered dexamethasone and RU 38486 on morphine analgesia in mice.
Topics: Analgesia; Animals; Dexamethasone; Injections, Intraperitoneal; Injections, Intraventricular; Male; Mice; Mifepristone; Morphine; Pain; Pain Measurement; Receptors, Glucocorticoid; Sensory Thresholds | 1991 |